查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362865

人类生长激素市场规模、份额、趋势分析报告：按配销通路、按用途、按产品、按地区、细分市场趋势，2023-2030

Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

人类生长激素市场成长与趋势

Grand View Research, Inc.最新报告显示，预计2030年全球人类生长激素市场规模将达到142.8亿美元，2023年至2030年年复合成长率为12.3%。

由于生长激素缺乏症和其他生长相关疾病的日益罹患率，市场正在见证成长。致力于开发创新且具有成本效益的治疗方案的主要企业之间的激烈竞争也推动了市场的成长。父母对儿童生长的日益关注导致对人类生长激素 (HGH) 治疗的需求增加。 《今日加拿大》的一份报告强调，父母对儿童的身高表现出特别的兴趣，并愿意投资侏儒症的治疗方案。

同样，在中国，即使没有医学异常，儿童对 HGH 治疗的需求也很高。人们对儿童正常发育的日益关注正在为行业相关人员创造新的机会。在该地区公众医疗保健意识不断提高、重要的政府倡议和有利的报销政策的推动下，北美地区预计将经历快速增长。此外，活性化研发活动、确保充足的研究资金以及积极宣传和治疗方法方案的组织的存在预计将推动该地区的市场成长。

此外，北美市场拥有辉瑞（Pfizer）和礼来（Lilly）等主要企业的大量业务，为全球市场的高盈利收益占有率做出了重大贡献。越来越多的法规核准和创新 HGH治疗方法的推出也有助于市场扩张。例如，2022 年 1 月，辉瑞公司和 OPKO Health, Inc. 获得美国食品药物管理局(FDA) 的给药，推出先进的每週一次的长效生长激素注射液，用于治疗生长激素缺乏症。我们已获得药物NGENLA 的上市核准。 NGENLA 预计将于 2023 年 8 月开始在美国上市。

同样，2021年8月，美国FDA核准了Ascengis Pharma推出的lonapeg somatropin-tcgd (SKYTROFA)，用于治疗儿童患者的生长停滞。这些法规的核准和新 HGH 治疗方案的推出有助于市场扩张并促进该领域的进一步发展。由于大众对生长激素缺乏症及其治疗方法的认识不断提高，以及对早期诊断的重视，北美在 2022 年占据了最大的销售份额。由于领先公司的投资增加和仿製药的快速采用，预计亚太地区在预测期内将呈现最快的年复合成长率。

印度和中国人口众多，预计将为医疗保健领域的发展提供巨大机会。因此，製药公司，包括专门生产 HGH 药物的製药公司，正在这些国家进行大量投资。辉瑞、诺华、默克和梯瓦製药公司主导全球市场。这些公司正在采取新产品开发、併购、联盟等策略来扩大市场占有率。 2023 年 6 月，全球健康与健身产业的领导者 Domestic Supply 推出了经过科学检验的HGH 补充品。这项创新产品代表了性能增强和整体健康领域的显着进步，为世界各地意愿健康的人们提供了更高的生活品质。

人类生长激素市场报告亮点

  • 从按产品来看，包括短效生长激素在内的其他细分市场将在 2022 年占据市场主导地位。越来越多的法规核准短效 GH 疗法以及该领域持续的研发活动正在促进市场成长。
  • 由于对人类生长激素缺乏症治疗和早期诊断的高度认识，加上全球市场上新药的推出，生长激素缺乏症用途领域在 2022 年占据市场主导地位。
  • 根据最终用途，由于人们对生长激素缺乏症及其治疗功效的认识不断提高，医院就诊次数增加，医院药房领域将在 2022 年占据主导地位。
  • 重组 DNA 技术在众多药品的设计和製造中发挥着重要作用，特别是那些用于患有生长激素缺乏症的成人和儿童的生长激素替代疗法的药品。
  • 预计该市场将在 2022 年成为第二大测试领域，家庭 A1C 测试领域的收益将增加。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第4章产品经营分析

  • 人类生长激素市场：产品波动分析
  • 长效
    • 长期市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第5章应用业务分析

  • 人类生长激素市场：应用变化分析
  • 生长激素缺乏症
  • 特纳氏症候群
  • 原发性矮小症
  • 普瑞德威利症候群
  • 小于胎龄
  • 其他的

第6章配销通路业务分析

  • 人类生长激素市场：配销通路波动分析
  • 医院药房
    • 医院药局市场，2018-2030
  • 零售药房
    • 零售药局市场，2018-2030
  • 网路药房
    • 2018-2030年网路药局市场
  • 专业药房
    • 专业药局市场，2018-2030

第7章区域业务分析

  • 2022 年及 2030 年人类生长激素市场占有率（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Novo Nordisk A/S
    • Pfizer, Inc
    • Eli Lilly and Company
    • Sandoz International GmbH（Novartis AG）
    • Merck KGaA
    • Genentech, Inc（Roche）
    • Ferring Pharmaceuticals
    • Teva Pharmaceutical Industries, Ltd
    • Ipsen
Product Code: GVR-2-68038-057-6

Human Growth Hormone Market Growth & Trends:

The global human growth hormone market size is expected to reach USD 14.28 billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is witnessing growth due to an increase in the incidence of growth hormone deficiency and other growth-related disorders. In addition, market growth is being driven by intense competition among key players striving to develop innovative and cost-effective treatment options. The increasing parental concerns regarding the growth of their children are contributing to the rising demand for human growth hormone (HGH) therapy. Reports from Canada Today highlight that parents are showing particular concern about the height of their children and are willing to invest in treatment options for dwarfism.

Similarly, in China, there is a high demand for HGH treatment for children, even in the absence of any medical abnormality. These growing concerns about the normal development of children have opened up new opportunities for industry players. North America is projected to experience rapid growth driven by increasing healthcare awareness among the population, significant government initiatives, and favorable reimbursement policies in the region. Furthermore, a rise in research & development activities, the availability of sufficient research funding, and the presence of organizations that actively promote awareness & treatment options are expected to drive the regional market growth.

In addition, the North America market benefits from the strong presence of top industry players, including Pfizer Inc. and Lilly, which significantly contributes to its profitable revenue share in the global industry. The increasing number of regulatory approvals and the introduction of innovative HGH treatment regimens are also contributing to the market expansion. For instance, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the U.S. Food and Drug Administration (FDA) for NGENLA's commercialization, an advanced long-acting growth hormone injection with a once-a-week dosage for treating growth hormone deficiency in the country. NGENLA is anticipated to be available for prescription in the United States starting from August 2023.

Similarly, in August 2021, the U.S. FDA approved lonapegsomatropin-tcgd (SKYTROFA) introduced by Ascendis Pharma, for the treatment of development stoppage in pediatric patients. These regulatory approvals and the launch of novel HGH regimens are contributing to the market's expansion and driving further advancements in the field. North America held the largest revenue share in 2022 due to a rise in awareness among people about growth hormone deficiency and its treatments, along with an emphasis on early diagnosis. Asia Pacific is expected to exhibit the fastest CAGR over the forecast period due to the rising investments by leading players and the surge in generic adoption in the region.

India and China are anticipated to offer significant opportunities for the advancement of the healthcare sector, driven by their large population. Consequently, pharmaceutical companies, including those specializing in HGH drugs, are making substantial investments in these countries. Pfizer Inc., Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd. dominate the global market. These companies adopt strategies, such as new product development, merger & acquisition, and partnership, to increase their market share. In June 2023, the global health and fitness industry leader, Domestic Supply, launched a scientifically validated HGH supplement. This novel product marks a remarkable advancement in the field of performance enhancement and overall well-being, offering health-conscious individuals worldwide an enhanced quality of life

Human Growth Hormone Market Report Highlights:

  • Based on product, the others segment including the short-acting growth hormone dominated the market in 2022. Increased approvals by regulatory authorities for short-acting GH therapies, along with ongoing R&D activities in this field, contribute to the growth of the market
  • The growth hormone deficiency application segment dominated the market in 2022 due to the high awareness levels about the treatment of growth hormone deficiency and early diagnosis in humans, coupled with the introduction of new drugs in the global market
  • Based on the end-use, the hospital pharmacy segment dominated the market in 2022 due to the increased number of hospital visits driven by rising awareness about growth hormone deficiency and the effectiveness of its treatments
  • Recombinant DNA technology plays a crucial role in designing and manufacturing numerous drugs, particularly those used for growth hormone replacement treatment in both adults and children who suffer from growth hormone deficiency
  • The market is expected to witness increased revenue generation in the at-home A1C testing segment, positioning it as the second-largest testing segment in 2022, primarily driven by higher adoption rates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Application segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Distribution channel segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Application and Product Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of human growth hormone
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of human growth hormone
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets.
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Human Growth Hormone Market: Product Movement Analysis
  • 4.2. Long Acting
    • 4.2.1. Long Acting Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Human Growth Hormone Market: Application Movement Analysis
  • 5.2. Growth Hormone Deficiency
    • 5.2.1. Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.2. Adult Growth Hormone Deficiency
      • 5.2.2.1. Adult Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
    • 5.2.3. Pediatric Growth Hormone Deficiency
      • 5.2.3.1. Pediatric Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
  • 5.3. Turner Syndrome
    • 5.3.1. Turner Syndrome Market, 2018 - 2030 (USD Million)
  • 5.4. Idiopathic Short Stature
    • 5.4.1. Idiopathic Short Stature Market, 2018 - 2030 (USD Million)
  • 5.5. Prader-Willi Syndrome
    • 5.5.1. Prader-Willi Syndrome Market, 2018 - 2030 (USD Million)
  • 5.6. Small for Gestational Age
    • 5.6.1. Small for Gestational Age Market, 2018 - 2030 (USD Million)
  • 5.7. Other
    • 5.7.1. Other Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Human Growth Hormone Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.5. Specialty Pharmacy
    • 6.5.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Human Growth Hormone Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. U.S. Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. France Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.10. Denmark
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Competitive Scenario
      • 7.3.10.3. Regulatory Framework
      • 7.3.10.4. Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.3.11. Russia
      • 7.3.11.1. Key Country Dynamics
      • 7.3.11.2. Competitive Scenario
      • 7.3.11.3. Regulatory Framework
      • 7.3.11.4. Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. China Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. India Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.4.9. Singapore
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Novo Nordisk A/S
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Pfizer, Inc
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Eli Lilly and Company
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sandoz International GmbH (Novartis AG)
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Genentech, Inc (Roche)
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Ferring Pharmaceuticals
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Teva Pharmaceutical Industries, Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Ipsen
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Human Growth Hormone Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Europe Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Europe Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 UK Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 UK Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Germany Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Germany Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 France Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 France Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Italy Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Italy Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Italy Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Spain Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 Spain Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Spain Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Russia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Russia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Russia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Denmark Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Sweden Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Norway Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 China Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 China Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 China Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 India Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 India Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 South Korea Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 South Korea Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Japan Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Japan Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Singapore Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Singapore Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Singapore Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Australia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Australia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 Australia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Thailand Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Thailand Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Thailand Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Latin America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 74 Latin America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Latin America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Latin America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Brazil Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 Brazil Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Mexico Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Mexico Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 82 Mexico Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Argentina Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Argentina Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 Argentina Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 South Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 91 South Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 South Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 UAE Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 UAE Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 98 UAE Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Human Growth Hormone Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Human growth hormone market: Product outlook and key takeaways
  • Fig. 15 Human growth hormone market: Product movement analysis & market share 2022 & 2030
  • Fig. 16 Long-acting market, 2018 - 2030 (USD Million)
  • Fig. 17 Others market, 2018 - 2030 (USD Million)
  • Fig. 18 Human growth hormone market: Application outlook and key takeaways
  • Fig. 19 Human growth hormone market: Application movement analysis & market share 2022 & 2030
  • Fig. 20 Growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 21 Adult growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 22 Pediatric growth hormone deficiency market, 2018 - 2030 (USD Million)
  • Fig. 23 Turner syndrome market, 2018 - 2030 (USD Million)
  • Fig. 24 Idiopathic short stature market, 2018 - 2030 (USD Million)
  • Fig. 25 Prader-Willi syndrome market, 2018 - 2030 (USD Million)
  • Fig. 26 Small for gestational age market, 2018 - 2030 (USD Million)
  • Fig. 27 Other market, 2018 - 2030 (USD Million)
  • Fig. 28 Human growth hormone market: Distribution channel method outlook and key takeaways
  • Fig. 29 Human growth hormone market: Distribution channel method movement analysis & market share 2022 & 2030
  • Fig. 30 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 32 Online pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 33 Specialty pharmacy market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2022 & 2030
  • Fig. 36 Regional Market Dashboard
  • Fig. 37 Regional Market Place: Key Takeaways
  • Fig. 38 North America
  • Fig. 39 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Key Country Dynamics
  • Fig. 41 U.S. America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Key Country Dynamics
  • Fig. 43 Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Key Country Dynamics
  • Fig. 46 UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Key Country Dynamics
  • Fig. 48 Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Key Country Dynamics
  • Fig. 50 France Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 51 Italy Key Country Dynamics
  • Fig. 52 Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Key Country Dynamics
  • Fig. 54 Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Key Country Dynamics
  • Fig. 56 Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Key Country Dynamics
  • Fig. 58 Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark Key Country Dynamics
  • Fig. 60 Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 61 Russia Key Country Dynamics
  • Fig. 62 Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 63 Turkey Key Country Dynamics
  • Fig. 64 Turkey Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 66 Japan Key Country Dynamics
  • Fig. 67 Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 68 China Key Country Dynamics
  • Fig. 69 China Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 70 India Key Country Dynamics
  • Fig. 71 India Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 72 Australia Key Country Dynamics
  • Fig. 73 Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand Key Country Dynamics
  • Fig. 75 Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea Key Country Dynamics
  • Fig. 77 South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 78 Indonesia Key Country Dynamics
  • Fig. 79 Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil Key Country Dynamics
  • Fig. 82 Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 83 Mexico Key Country Dynamics
  • Fig. 84 Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina Key Country Dynamics
  • Fig. 86 Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa America Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa Key Country Dynamics
  • Fig. 89 South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Key Country Dynamics
  • Fig. 91 Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Key Country Dynamics
  • Fig. 93 UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Key Country Dynamics
  • Fig. 95 Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 96 Nigeria Key Country Dynamics
  • Fig. 97 Nigeria Human Growth Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 98 Strategy Mapping